Cargando…

The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients

AIMS: To evaluate the relation between residential distance and total ischaemic time in patients with acute ST-elevation myocardial infarction (STEMI). METHODS: STEMI patients were transported to the Isala Hospital Zwolle with the intention to perform primary percutaneous coronary intervention PCI (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Postma, S., Dambrink, J. H. E., de Boer, M. J, Gosselink, A. T. M., Ottervanger, J. P., Koopmans, P. C., ten Berg, J. M., Suryapranata, H., van ’t Hof, A. W. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391176/ https://www.ncbi.nlm.nih.gov/pubmed/25273920 http://dx.doi.org/10.1007/s12471-014-0599-8

Ejemplares similares

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study
por: Postma, Sonja, et al.
Publicado: (2015)

Are patients with non-ST elevation myocardial infarction undertreated?
por: Rasoul, Saman, et al.
Publicado: (2007)

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
por: Remkes, Wouter S, et al.
Publicado: (2016)

Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study
por: Otten, Amber M, et al.
Publicado: (2013)

Diagnosis of takotsubo cardiomyopathy is increasing over time in patients presenting as ST-elevation myocardial infarction
por: Otten, A.M., et al.
Publicado: (2016)

Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial
por: de Boer, M.-J., et al.
Publicado: (2022)

ST-segment elevation myocardial infarction: Historical perspective and new horizons
por: Zijlstra, F., et al.
Publicado: (2020)

Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry
por: Badings, E. A., et al.
Publicado: (2018)

Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry
por: Kilic, S., et al.
Publicado: (2016)

The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]
por: van der Horst, Iwan CC, et al.
Publicado: (2005)

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
por: Schellings, Dirk AAM, et al.
Publicado: (2016)

Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, Anne H, et al.
Publicado: (2020)

Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial
por: Tavenier, Anne H., et al.
Publicado: (2021)

Non-ST-elevation myocardial infarction in the Netherlands: room for improvement!
por: Ten Have, P., et al.
Publicado: (2020)

2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group
por: Arslan, F., et al.
Publicado: (2018)

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction
por: Velders, M. A., et al.
Publicado: (2014)

A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, A. H., et al.
Publicado: (2019)

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome
por: Badings, Erik A, et al.
Publicado: (2017)

Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus
por: Kennedy, Mark W., et al.
Publicado: (2016)

Mistaken ST-Elevation Myocardial Infarction
por: Wolk, Brian J.
Publicado: (2015)

Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome
por: Hoedemaker, N. P. G., et al.
Publicado: (2017)

Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions
por: Demirkiran, Ahmet, et al.
Publicado: (2021)

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction
por: van den Brink, F. S., et al.
Publicado: (2017)

Predictors of left ventricular remodeling after ST-elevation myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2017)

Examining the Timeliness of ST-elevation Myocardial Infarction Transfers
por: Ward, Michael J., et al.
Publicado: (2021)

Optimal pharmacological therapy in ST-elevation myocardial infarction—a review: A review of antithrombotic therapies in STEMI
por: Hermanides, R. S., et al.
Publicado: (2018)

Multi‐Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non–ST‐Segment–Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay
por: Damen, Sander A. J., et al.
Publicado: (2019)

Concurrent subarachnoid haemorrhage and ST elevation myocardial infarction
por: Tan, Joon H, et al.
Publicado: (2017)

Inferior acute myocardial infarction with anterior ST-segment elevations
por: Bouhuijzen, L. J., et al.
Publicado: (2018)

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
por: Lexis, Chris P. H., et al.
Publicado: (2012)

The Impact of COVID-19 on ST Elevation Myocardial Infarction
por: Femia, G., et al.
Publicado: (2021)

Risk of cancer after ST-segment-elevation myocardial infarction
por: Leening, Maarten J. G., et al.
Publicado: (2023)

Cardiac Metastasis Presenting as ST-Elevation Myocardial Infarction
por: Lewis, Michael J
Publicado: (2023)

The Barriers to Rapid Reperfusion in Acute ST-Elevation Myocardial Infarction
por: Bartnes, Kristian, et al.
Publicado: (2022)

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group
por: Damman, P., et al.
Publicado: (2016)

Takotsubo Syndrome Associated with ST Elevation Myocardial Infarction
por: Ezad, Saad, et al.
Publicado: (2019)

ST-elevation myocardial infarction risk in the very elderly
por: Campos, Alessandra M., et al.
Publicado: (2016)

Dexmedetomidine Withdrawal Mimicking ST-Elevation Myocardial Infarction
por: Lakra, Pallavi, et al.
Publicado: (2023)

Sharing primary percutaneous coronary intervention care: first experiences with South Limburg ST-elevation myocardial infarction network
por: Lux, A., et al.
Publicado: (2021)

Direct admission versus interhospital transfer for revascularisation in non‐ST‐segment elevation myocardial infarction
por: van Steenbergen, Gijs J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7atvdmgsq1o0ij5icua7aiulih